Meridian Medical Technologies, the manufacturer of Mylan’s EpiPen-brand of epinephrine auto-injectors, has announced a voluntary recall of selected EpiPen lots due to safety concerns.
According to the company, a potential defect in a component of the auto-injector could make the device difficult to activate in an emergency situation, potentially resulting in significant health consequences for patients experiencing a life-threatening allergic reaction.
The EpiPens subject to recall were distributed by Mylan between December 2015 and July 2016, and impact the 0.3 mg and 0.15 mg strengths. Originally limited to the U.S., the recall has recently been expanded to include markets in Europe, Asia, North and South America.
Read additional details about this recall, including a listing of the affected lot numbers.
